[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases.
Ivanidze J, Sharbatdaran A, McCalla A, Brandmaier A, Andreopoulou E, Cristofanilli M, Cigler T, Balogun OD, Magge RS, Liechty B, Karakatsanis NA, Nehmeh SA, Agee MA, Jean J, Osborne JR, Beal K, Schwartz TH, Pannullo SC, Knisely JPS, Ramakrishna R.
Ivanidze J, et al. Among authors: schwartz th.
Eur J Radiol. 2024 Dec;181:111791. doi: 10.1016/j.ejrad.2024.111791. Epub 2024 Oct 15.
Eur J Radiol. 2024.
PMID: 39423781